Parallel studies in Drosophila melanogaster showed an 11-16% extension of mean lifespan across multiple dosage groups
Characterization of the mouse promoter region of the acyl-CoA synthetase 4 gene: role of Sp1 and CREB
What the Future Holds Research on GLP-1 medications and blood pressure continues
It is one of the most extensively researched peptides in the recovery category, with studies investigating its effects on tendon, muscle, and ligament healing, angiogenesis, and cytoprotective mechanisms
Insurance Coverage Gaps Many insurance plans refuse to cover GLP-1 medications unless the patient also has type 2 diabetes
Summary: Gila monster venom contains exendin-4, a peptide that mimics human GLP-1 but resists rapid breakdown, leading to the development of long-acting GLP-1 receptor agonists now used to treat type 2 diabetes